"Gelatinases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of enzymes that catalyzes the degradation of gelatin by acting on the peptide bonds. EC 3.4.24.-.
Descriptor ID |
D018093
|
MeSH Number(s) |
D08.811.277.656.300.480.252 D08.811.277.656.675.374.252
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gelatinases".
Below are MeSH descriptors whose meaning is more specific than "Gelatinases".
This graph shows the total number of publications written about "Gelatinases" by people in this website by year, and whether "Gelatinases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 1 | 0 | 1 |
1996 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2011 | 0 | 2 | 2 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gelatinases" by people in Profiles.
-
Akinboye ES, Brennen WN, Rosen DM, Bakare O, Denmeade SR. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy. Prostate. 2016 Jun; 76(8):703-14.
-
Nyunoya T, March TH, Tesfaigzi Y, Seagrave J. Antioxidant diet protects against emphysema, but increases mortality in cigarette smoke-exposed mice. COPD. 2011 Oct; 8(5):362-8.
-
Souvenir R, Fathali N, Ostrowski RP, Lekic T, Zhang JH, Tang J. Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia. Neurobiol Dis. 2011 Oct; 44(1):28-37.
-
Baba Y, Yasuda O, Takemura Y, Ishikawa Y, Ohishi M, Iwanami J, Mogi M, Doe N, Horiuchi M, Maeda N, Fukuo K, Rakugi H. Timp-3 deficiency impairs cognitive function in mice. Lab Invest. 2009 Dec; 89(12):1340-7.
-
Wang G, Guo Q, Hossain M, Fazio V, Zeynalov E, Janigro D, Mayberg MR, Namura S. Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain Res. 2009 Oct 19; 1294:183-92.
-
Ochieng J, Green B, Evans S, James O, Warfield P. Modulation of the biological functions of galectin-3 by matrix metalloproteinases. Biochim Biophys Acta. 1998 Jan 08; 1379(1):97-106.
-
Qin X, Chua PK, Ohira RH, Bryant-Greenwood GD. An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). Biol Reprod. 1997 Apr; 56(4):812-20.
-
Ochieng J, Green B. The interactions of alpha 2HS glycoprotein with metalloproteinases. Biochem Mol Biol Int. 1996 Sep; 40(1):13-20.
-
Ochieng J, Warfield P, Green B. Interactions of gelatinases with soluble and immobilized fetuin and asialofetuin. Arch Biochem Biophys. 1995 Sep 10; 322(1):250-5.
-
Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, Stetler-Stevenson WG, Raz A. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry. 1994 Nov 29; 33(47):14109-14.